NGF and Alzheimer disease: Currently, there is an ongoing gene therapy trial using NGF-grafted autologous fibroblasts that were injected into the basal nucleus of Meynert (nbM) (Tuszynski et al.2005) with the aim to rescue the BFCN of AD patients.